This article is more than 5 years old. Information may no longer be current.
Top stories in endocrinology: FDA OKs first triple combination pill for diabetes, apps help people with diabetes lose weight
The FDA approved Trijardy XR, the first oral therapy to combine three type 2 diabetes medications into one pill. It was the week’s top story in endocrinology.
Another top story was about a study that found people with type 2 diabetes may lose weight more effectively if they used a weight-loss mobile app.
FDA approves first triple combination pill for type 2 diabetes
The FDA approved the first oral therapy to combine three type 2 diabetes medications into one pill: the SGLT2 inhibitor empagliflozin, the DPP-IV inhibitor linagliptin and metformin hydrochloride extended release, according to a press release from Boehringer Ingelheim and Eli Lilly and Co. Read more.
Mobile apps may facilitate weight loss among adults with type 2 diabetes
Adults with type 2 diabetes may lose weight more effectively by including a weight-loss mobile app as part of their strategy, according to findings from a meta-analysis published in Obesity. Read more.
New genetic discoveries help predict risk for type 1, type 2 diabetes
Researchers continue to discover more each year about the genetic risk factors for type 1 and type 2 diabetes and how those risk factors interact with the environment. Scientists have linked several genetic mutations to diabetes risk, though not everyone with a genetic mutation will go on to develop the disease. Read more.
Dual-hormone artificial pancreas ‘next logical treatment’ for type 1 diabetes
Adults with type 1 diabetes may be able to maintain their glucose levels in target range longer, particularly during the day, by using an artificial pancreas with rapid-acting insulin and pramlintide, according to findings published in Diabetes Care. Read more.
High childhood HbA1c increases premature death risk in type 1 diabetes
Young adults with type 1 diabetes were nearly three times more likely to die before age 30 years if they had poor metabolic control during childhood, according to findings from a Swedish registry-based study. Read more.